+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia



Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia



European Journal of Clinical Microbiology and Infectious Diseases 29(5): 509-518



Expanding knowledge on the humoral immune response in Staphylococcus aureus-infected patients is a mandatory step in the development of vaccines and immunotherapies. Here, we present novel insights into the antibody responses following S. aureus bacteremia. Fifteen bacteremic patients were followed extensively from diagnosis onwards (median 29 days, range 9-74). S. aureus strains (median 3, range 1-6) and serial serum samples (median 16, range 6-27) were collected. Strains were genotyped by pulsed-field gel electrophoresis (PFGE) and genes encoding 19 staphylococcal proteins were detected by polymerase chain reaction (PCR). The levels of IgG, IgA, and IgM directed to these proteins were determined using bead-based flow cytometry. All strains isolated from individual patients were PFGE-identical. The genes encoding clumping factor (Clf) A, ClfB, and iron-responsive surface-determinant (Isd) A were detected in all isolates. Antigen-specific IgG levels increased more frequently than IgA or IgM levels. In individual patients, different proteins induced an immune response and the dynamics clearly differed. Anti-ClfB, anti-IsdH, and anti-fibronectin-binding protein A IgG levels increased in 7 of 13 adult patients (p < 0.05). The anti-IsdA IgG level increased in 12 patients (initial to peak level: 1.13-10.72 fold; p < 0.01). Peak level was reached 7-37 days after diagnosis. In a bacteremic 5-day-old newborn, antistaphylococcal IgG levels declined from diagnosis onwards. In conclusion, each bacteremic patient develops a unique immune response directed to different staphylococcal proteins. Therefore, vaccines should be based on multiple components. IsdA is immunogenic and, therefore, produced in nearly all bacteremic patients. This suggests that IsdA might be a useful component of a multivalent staphylococcal vaccine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053526398

Download citation: RISBibTeXText

PMID: 20186449

DOI: 10.1007/s10096-010-0888-0


Related references

Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. Plos one 8(1): E53391, 2013

Humoral immune consequences of Staphylococcus aureus ST239-associated bacteremia. European Journal of Clinical Microbiology and Infectious Diseases 37(2): 255-263, 2018

Abnormal humoral immune response to Staphylococcus aureus in patients with Staphylococcus aureus hyper IgE syndrome. Clinical and Experimental Immunology 66(2): 450-456, 1986

Immune complex glomerulonephritis associated with Staphylococcus aureus bacteremia: response to corticosteroid therapy. Reviews of Infectious Diseases 12(1): 125-127, 1990

Immunization of young heifers with staphylococcal immune evasion proteins before natural exposure to Staphylococcus aureus induces a humoral immune response in serum and milk. Bmc Veterinary Research 15(1): 15, 2019

Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus. European Journal of Clinical Microbiology and Infectious Diseases 36(3): 451-458, 2017

Humoral immune response to staphylococcus aureus in experimental osteomyelitis using immunoblot and gel diffusion. Abstracts of the Annual Meeting of the American Society for Microbiology 86: 91, 1986

Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. Antimicrobial Agents and ChemoTherapy 51(12): 4249-4254, 2007

Role of t lymphocytes in the development of humoral immune response to corpuscular antigen of staphylococcus aureus. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (1): 72-75, 1990

Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. Journal of Infectious Diseases 199(5): 625-632, 2009

Staphylococcus aureus Bacteremia in Patients not Meeting Sepsis Criteria: Clinical Features, Host Immune Response and Outcomes. Journal of Clinical Medicine and Therapeutics 2(4):, 2017

Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. Journal of the American College of Surgeons 190(1): 50-57, 2000

Humoral immune response to staphylococcal cell walls in patients with the staphylococcus aureus hyper immuno globulin e syndrome. Immunobiology 160(1): 105, 1981

2 3 7 8 tcdd has effects on the in vitro t dependent humoral immune response which are similar to that of the polyclonal b cell activator staphylococcus aureus cowan i sac. FASEB Journal 4(7): A1726, 1990

Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus. Genetics and Molecular Research 5(3): 503-512, 2006